Healx Announces $47 million Series C Financing and FDA Clearance of Phase 2 IND for Neurofibromatosis Type 1 Trial

Remembering Dr. Neil T. Thompson

Video: Working together to end Neurofibromatosis - speech at the CTF Patient Summit 2024